Nasal bone assessment in prenatal screening for trisomy 21

被引:128
作者
Sonek, J. D.
Cicero, S.
Neiger, R.
Nicolaides, K. H.
机构
[1] Ohio State Univ, Dept Obstet & Gynecol, Dayton, OH USA
[2] Wright State Univ, Dept Obstet & Gynecol, Dayton, OH 45435 USA
[3] Fetal Med Fdn, London, England
[4] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England
关键词
nasal bone absence; nasal bone hypoplasia; trisomy; 21; chromosomal defects; ultrasound; X-ray; histomorphology; prenatal screening;
D O I
10.1016/j.ajog.2005.11.042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A small nose is a common facial feature of individuals with trisomy 21. Evidence based on radiologic, histomorphologic, and sonographic studies shows that nasal bone abnormalities are significantly more common in trisomy 21 fetuses than in euploid fetuses. These abnormalities, which include both nasal bone absence and short nasal bone length, can be detected by prenatal ultrasound. In this article we review the evidence and discuss the potential value of assessment of the fetal nasal bone in screening for trisomy 21. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:1219 / 1230
页数:12
相关论文
共 57 条
[1]  
BECK JC, 1999, FUNCTIONAL RECONSTRU, V2, P57
[2]   Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in second-trimester screening for Down syndrome [J].
Benoit, B ;
Chaoui, R .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2005, 25 (01) :19-24
[3]  
BOULEY R, 2003, DS NEWS, V10, P33
[4]   Fetal nose bone length - A marker for Down syndrome in the second trimester [J].
Bromley, B ;
Lieberman, E ;
Shipp, TD ;
Benacerraf, BR .
JOURNAL OF ULTRASOUND IN MEDICINE, 2002, 21 (12) :1387-1394
[5]   The genetic sonogram - A method of risk assessment for Down syndrome in the second trimester [J].
Bromley, B ;
Lieberman, E ;
Shipp, TD ;
Benacerraf, BR .
JOURNAL OF ULTRASOUND IN MEDICINE, 2002, 21 (10) :1087-1096
[6]   Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21 [J].
Bunduki, V ;
Ruano, R ;
Miguelez, J ;
Yoshizaki, CT ;
Kahhale, S ;
Zugaib, M .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 21 (02) :156-160
[7]   Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan [J].
Cicero, S ;
Rembouskos, G ;
Vandecruys, H ;
Hogg, M ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2004, 23 (03) :218-223
[8]   Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks [J].
Cicero, S ;
Dezerega, V ;
Andrade, E ;
Scheier, M ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (02) :135-137
[9]   Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks [J].
Cicero, S ;
Bindra, R ;
Rembouskos, G ;
Spencer, K ;
Nicolaides, KH .
PRENATAL DIAGNOSIS, 2003, 23 (04) :306-310
[10]  
Cicero S, 2002, J Matern Fetal Neonatal Med, V11, P400, DOI 10.1080/713605572